Caricamento...
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
Amyloid-β (Aβ) and tau proteins currently represent the two most promising targets to treat Alzheimer's disease. The most extensively developed method to treat the pathologic forms of these proteins is through the administration of exogenous antibodies, or passive immunotherapy. In this review,...
Salvato in:
| Pubblicato in: | Neurobiol Dis |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Authors. Published by Elsevier Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7365083/ https://ncbi.nlm.nih.gov/pubmed/32682954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2020.105010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|